Article
microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
3 Dec 2019
Abstract excerpt
Relapsed disease following first-line therapy remains one of the central problems in cancer management, including chemotherapy, radiotherapy, growth factor receptor-based targeted therapy, and immune checkpoint-based immunotherapy. Cancer cells develop therapeutic resistance through both intrinsic and extrinsic mechanisms including cellular heterogeneity, drug tolerance, bypassing alternative signaling pathways,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
